Focused articles on AI visibility, SEO, and sustainable growth for life sciences companies.
Watch how VayoMed’s SIUU status review handles FDA implementation wording, OMB collection approvals and the review record for scientific communications.
Watch an overview of EU AI Act Article 50, substantive human review and editorial responsibility for AI-assisted public-interest content.
Get the latest insights on AI visibility and life sciences marketing delivered to your inbox.
No spam. Unsubscribe anytime.
Use FDA guidance, enforcement cases and classification data to distinguish wellness, device and software claims across websites, interfaces and communications.
Watch how to choose research topics around buyer decisions, maintain accessible evidence, and measure production effort separately from AI citations.
Watch how legal names, brands and local holders affect cross-market findability, using a matched cohort of NIH device awardees with FDA clearance.
Watch how wire pickup links, redirects and link attributes affect the path back to your company, and how to choose useful owned destinations.
Watch why product PDFs need clear landing pages, revision dates and links from the right product pages, using findings from VayoMed’s website audit.
Watch how one durable product page can connect FDA clearance wording, public evidence, news updates and buyer inquiries across your digital presence.
Watch how training crawlers and AI search crawlers differ, what a life sciences robots.txt audit found, and how to check access to important pages.
Watch what six life sciences wire campaigns reveal about pickups, website reach, crawler activity and the owned pages that a release should lead to.
Separate Form 6-K filing rules, English translations and incorporation by reference from the life-sciences communications workflow and its review record.
Watch how a 40-market ultrasound model separates market ranking from language investment, with practical steps for choosing sustainable website locales.
Watch a practical breakdown of salary, benefits, part-time roles and coordination costs when building an in-house growth operation for life sciences.
Watch the differences between FDA clearance, De Novo grants and PMA approval, and how to keep device status wording consistent across public communications.
Watch how AI recommendation lists vary across models, why citation sources matter, and which company pages help buyers verify your business.
Watch how a life sciences website can help buyers verify FDA clearance, find product evidence, and understand your company in search and AI answers.
Reconcile FDA’s SIUU implementation notice with later OMB approvals, then classify life-sciences communications and preserve review across derivative content.
Compare life-sciences filings from the year 2026: required announcement text, other exhibits, furnished versus filed treatment and disclosure deadlines.
EU AI Act Article 50(4) applies from 2 August 2026. Sort five AI-written life-sciences outputs and see the review record that lets a disease page skip the label.
Audit 64 research artifacts and 188 brand snapshots to plan useful MedTech content, maintain its evidence and measure search, citations and qualified demand.
Audit FDA status wording across device pathways, websites, press releases and AI answers, with a practical claims matrix and clearly bounded evidence.
An 188-domain audit tests crawler policies, page access and metadata, then turns bounded source panels into a practical MedTech website release checklist.
A 40-market evidence model turns trade, access, language, digital readiness, and delivery constraints into a practical website localization sequence.
We joined NIH device awards, FDA 510(k)s, federal contracts, and ten public registers to measure the public-evidence gap after funding and clearance.
We analyzed 40 capped AI recommendation panels, 1,689 citations, and 188 brand reports to show what an AI shortlist does—and does not—measure.
We audited six life-sciences PR Newswire campaigns: 1,159 pickups, crawler traffic, link markup, AI citations, durability, and click economics.
We rebuilt our own $200,000-$300,000 comparison claim from federal wage data. A realistic in-house configuration costs $220,888 a year - and here is every line of the arithmetic.
A 60-company audit reveals where newly cleared MedTech websites break between FDA records, product findability, regulatory evidence, and buyer inquiry.
We measured how often the 160 largest FDA-registered medtech brands get cited by ChatGPT and Google AI. The result is a winner-take-most gap — and a clear GEO playbook.
68% of procurement teams now use AI for vendor research. Learn how Generative Engine Optimization (GEO) determines which medical devices get recommended.
